Anti-Human CD274 Recombinant Antibody(Atezolizumab)

Name: Anti-Human CD274 Recombinant Antibody(Atezolizumab)
Brand: KMD Bioscience
SKU: YR1354

YR1354

科研级 Atezolizumab ( 阿特利珠单抗 ), Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab

DATASHEET MSDS

Product Description

Alias	科研级 Atezolizumab ( 阿特利珠单抗 ), Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab
Catalog Number	YR1354
Molecular Name	Atezolizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
CAS Number	1380723-44-3
Application	ELISA, IHC, IF, IP, FCM
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	144.59 kDa
Target	CD274[Homo sapiens]

Login